MITEK SYSTEMS INC (MITK): Nasdaq/NYSE listing notice — Mitek receives additional Nasdaq delisting notice for Q3 10-Q miss; corrects prior filing error

MITEK SYSTEMS INC

Corrected prior 8-K typo: now says company does not need to address Q3 10-Q filing further with Panel.
Nasdaq notified Mitek on Aug 14, 2023 of failure to file Q3 10-Q as additional delisting basis.
Hearing held Aug 10, 2023; company presented plan to become current in filings.
Company expects Panel decision on continued listing in late August or September 2023.
Annual Report for FY2022 already filed; Q1, Q2, Q3 10-Qs to be filed promptly.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

MITEK SYSTEMS INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

August 14, 2023, Mitek Systems, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), as expected, advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Q3 Form 10-Q”) in a timely manner and that such matter serves as an additional basis for delisting the Company’s securities from Nasdaq. The Rule requires

View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

MITEK SYSTEMS INC filing history →

Source: SEC EDGAR

accession 0000807863-23-000069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.